| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/10/2012 | US8092794 Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
| 01/10/2012 | US8092791 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
| 01/10/2012 | US8092788 Compositions and methods for topical diagnostic and therapeutic transport |
| 01/10/2012 | US8092781 Treatment of sinusitis in mammals with clostridia neurotoxins |
| 01/10/2012 | US8092780 Polyvalent conjugate vaccine for cancer |
| 01/10/2012 | CA2533332C Therapeutic compounds |
| 01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
| 01/10/2012 | CA2428144C Compositions of interferon-beta stabilized with highly purified mannitol |
| 01/10/2012 | CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2400295C Modified factor viii |
| 01/10/2012 | CA2398726C High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 01/10/2012 | CA2354029C Gene therapy for cardiomyopathy |
| 01/10/2012 | CA2348167C Pharmaceutical administration form for peptides, process for its preparation, and use |
| 01/10/2012 | CA2334483C Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 01/10/2012 | CA2267650C Non-naturally occurring lipoprotein particle |
| 01/05/2012 | WO2012003516A2 Preservative-free follicle stimulating hormone solution delivery device |
| 01/05/2012 | WO2012003466A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | WO2012003452A2 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | WO2012003398A1 Method for uses of protein precursors as prodrugs |
| 01/05/2012 | WO2012003370A2 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | WO2012003281A2 Small-molecule-targeted protein degradation |
| 01/05/2012 | WO2012002986A2 Decellularized and delipidized extracellular matrix and methods of use |
| 01/05/2012 | WO2012002762A2 Peptide for the treatment or prevention of allergic diseases |
| 01/05/2012 | WO2012002668A2 Novel peptide and use thereof |
| 01/05/2012 | WO2012002582A1 Partial region polypeptide of reic/dkk-3 protein |
| 01/05/2012 | WO2012002562A1 Modified protein therapeutics |
| 01/05/2012 | WO2012002522A1 Therapeutic agent for indications for haloperidol, and beverage or food |
| 01/05/2012 | WO2012001641A1 Stable pharmaceutical compositions |
| 01/05/2012 | WO2012001469A1 Desmopressin for reducing nocturnal voids |
| 01/05/2012 | WO2012001245A1 Sirtuin-6-activating peptides, and cosmetic or pharmaceutical compositions including same |
| 01/05/2012 | WO2012001149A2 Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells |
| 01/05/2012 | WO2012000930A1 A method for preparing a bone protein preparation and a bone protein preparation |
| 01/05/2012 | WO2012000906A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 01/05/2012 | WO2012000459A1 Anti-hiv infection polypeptide, composition, and use |
| 01/05/2012 | WO2012000458A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 01/05/2012 | WO2012000409A1 Peptides with activity of inhibiting angiogenesis and uses thereof |
| 01/05/2012 | WO2012000187A1 Fusion protein of g-csf variant, preparation method and use thereof |
| 01/05/2012 | WO2012000180A1 Method for preparing dermis tissue cells aggregation and uses thereof |
| 01/05/2012 | WO2012000118A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | WO2012000113A1 Keloid treatment |
| 01/05/2012 | WO2012000087A1 Compositions and methods for controlling blood glucose levels |
| 01/05/2012 | WO2012000054A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 01/05/2012 | WO2011143559A3 Compositions and methods which modulate g-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis |
| 01/05/2012 | WO2011143335A3 Methods for treatment or prophylaxis of kidney or liver dysfunction |
| 01/05/2012 | WO2011142858A3 Chlorotoxin variants, conjugates, and methods for their use |
| 01/05/2012 | WO2011141824A3 Methods for identifying nmda receptor modulators |
| 01/05/2012 | WO2011139819A3 Creation of oxidation-resistant hdl mimetic peptides |
| 01/05/2012 | WO2011133948A3 Highly active polypeptides and methods of making and using the same |
| 01/05/2012 | WO2011126853A9 Prevention or delay of onset of oral mucositis |
| 01/05/2012 | WO2011125040A3 New polyterpene type compounds, compositions containing them and topical uses thereof |
| 01/05/2012 | WO2011117685A3 Contraceptive peptides derived from spider venom |
| 01/05/2012 | WO2011115728A3 Polynucleotides that stimulate neutrophils |
| 01/05/2012 | WO2011109834A3 Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
| 01/05/2012 | WO2011096775A3 Two-stage apparatus for artificial insemination, capable of simultaneously carrying reproductive cells of cattle and fertilization promoting materials and injecting the reproductive cells and the fertilization promoting materials into a uterus through a single procedure |
| 01/05/2012 | WO2011093647A3 Genes implicated in osteoarthritis and use thereof |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2011075471A3 Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
| 01/05/2012 | WO2011064316A3 Mucosal delivery compositions comprising a peptide complexed with a crown comppound and/or a counter ion |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | WO2002026936A9 Gene expression in the central nervous system regulated by neuroleptic agents |
| 01/05/2012 | US20120005790 Analogs of temporin-sha and uses thereof |
| 01/05/2012 | US20120005777 Process for the Production of Fine Chemicals |
| 01/05/2012 | US20120004720 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 01/05/2012 | US20120004627 Apparatus and methods for enzymatic debridement of skin lesions |
| 01/05/2012 | US20120004396 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 01/05/2012 | US20120004187 Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| 01/05/2012 | US20120004186 Platelet aggregation inhibitor composition |
| 01/05/2012 | US20120004185 Polypeptide structural motifs associated with cell signaling activity |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004183 Unnatural reactive amino acid genetic code additions |
| 01/05/2012 | US20120004182 Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells |
| 01/05/2012 | US20120004181 Targeted delivery system |
| 01/05/2012 | US20120004180 Method of producing a novel opioid peptide |
| 01/05/2012 | US20120004179 Means and methods for manufacturing highly pure neurotoxin |
| 01/05/2012 | US20120004178 Biglycan mutants and related therapeutics and methods of use |
| 01/05/2012 | US20120004177 Compositions and methods of delivery of pharmacological agents |
| 01/05/2012 | US20120004176 Liquid Composition of Factor VII Polypeptides |
| 01/05/2012 | US20120004175 Inhibitors of nf-kb activity |
| 01/05/2012 | US20120004174 Gh secretagogues and uses thereof |
| 01/05/2012 | US20120004173 Methods and compositions for treating skin aging and scars |
| 01/05/2012 | US20120004172 Screening method of anti-lung or esophageal cancer compounds |
| 01/05/2012 | US20120004171 Novel therapies for chronic renal failure |
| 01/05/2012 | US20120004170 Formulation Comprising Bioactive Agents And Method Of Using Same |
| 01/05/2012 | US20120004169 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 01/05/2012 | US20120004168 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 01/05/2012 | US20120004167 (2-aryloxyacetylamino) phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120004166 Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| 01/05/2012 | US20120004165 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120004164 Organic compounds |
| 01/05/2012 | US20120004163 Nutritional composition for infants |
| 01/05/2012 | US20120004162 Methods of Treating an Overweight or Obese Subject |
| 01/05/2012 | US20120004161 Homogenous preparations of il-28 and il-29 |
| 01/05/2012 | US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 01/05/2012 | US20120004159 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 01/05/2012 | US20120004158 Quaternised Ammonium Cyclodextrin Compounds |
| 01/05/2012 | US20120004157 Hydroxyproline compositions and uses thereof |
| 01/05/2012 | US20120003337 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 01/05/2012 | US20120003321 Crosslinked Dextran Composite Magnetic Microparticles and Preparation Process and Using Method Thereof |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |